AbbVie
ABBV
$2.07 (1.26%)
1D
1W
3M
1Y
5Y
ALL
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
PRNewsWire • 2 days ago • ABBV
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week®InvestorPlace • 2 days ago • ABBV
7 Value Stocks to Buy and Hold for a Decade of DominanceZacks Investment Research • 3 days ago • ABBV
Are You Looking for a High-Growth Dividend Stock?InvestorPlace • 3 days ago • ABBV
Wall Street Favorites: 3 Retirement Stocks With Strong Buy Ratings for May 2024Seeking Alpha • 3 days ago • ABBV
AbbVie, Inc. (ABBV) Bank of America Health Care Conference Call TranscriptCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.